Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax
Completed
St. Luke's Hospital, Pennsylvania
Phase 2/Phase 3
2005-07-01
The purpose of this study is to examine the efficacy of prophylactic antibiotics in patients
with chest tubes for management of thoracic injuries in the reduction of the incidence of
empyema as compared to placebo.
Effectiveness of Topical Antibiotic Prophylaxis in Inguinal Hernia Repair
Completed
Diskapi Teaching and Research Hospital
Phase 4
2011-01-01
Aim of this study is to measure the effectiveness of topical gentamicin to prevent
post-operative infection in inguinal tension-free hernia repair operation.Secondary aim is,
if it is effective as a prophylactic agent, to compare it's effect with intra venous single
dose cefazolin sodium prophylaxis.
Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery
Completed
Ito Hospital
N/A
2010-11-01
The effectiveness of antimicrobial prophylaxis (AMP) for prevention of surgical site
infection (SSI) following thyroid and parathyroid surgery remains uncertain. Present
prospective randomized control study (Ito-RCT1) assessed the effectiveness of AMP in clean
neck surgery associated with thyroid and parathyroid disease.
Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
Completed
Fundação de Amparo à Pesquisa do Estado de São Paulo
Phase 4
2014-08-01
The purpose of this study is to assess whether the switch from branded to generic warfarin
or between different generic warfarin tablets may cause fluctuation in the results of
coagulation tests (International Normalized Rate, acronym INR) in patients, thus
predisposing them to unnecessary risks.
Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
Completed
Federal University of São Paulo
Phase 4
2014-08-01
The purpose of this study is to assess whether the switch from branded to generic warfarin
or between different generic warfarin tablets may cause fluctuation in the results of
coagulation tests (International Normalized Rate, acronym INR) in patients, thus
predisposing them to unnecessary risks.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
